Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Oct 1, 2008 goldstein joseph l Director Sell 500 22.32
Feb 4, 2010 roberts william Officer Automatic Sell 514 27.48 - 28.38
May 19, 2010 brown michael s Director Sell 524 27.73
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
Nov 5, 2007 brown michael s Director Automatic Sell 600 20.67 - 20.87
Jul 27, 2012 goldberg murray a Officer Disposition (Non Open Market) 600 n/a
Jul 14, 2011 vagelos p roy Officer Automatic Sell 658 56.43 - 57.07
Oct 9, 2013 vagelos p roy Officer Disposition (Non Open Market) 679 n/a
Apr 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 700 n/a
Aug 7, 2014 stahl neil Officer Sell 741 340.39 - 341.03
Jul 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 756 n/a
Jan 10, 2014 vagelos p roy Officer Disposition (Non Open Market) 764 n/a
Nov 5, 2007 goldstein joseph l Director Automatic Sell 800 20.64 - 20.87
Nov 5, 2007 goldstein joseph l Director Option Execute 800 7.66
Jul 5, 2013 vagelos p roy Officer Disposition (Non Open Market) 921 n/a
Feb 27, 2014 brown michael s Director Sell 1,000 335.00
Feb 26, 2014 brown michael s Director Option Execute 1,000 57.11
Dec 19, 2008 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Oct 21, 2010 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Aug 23, 2013 goldstein joseph l Director Sell 1,000 238.29
Showing 21-40 of 850 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)